Skip to main content
Mural Oncology plc (MURA)
NASDAQ: MURA · IEX Real-Time Price · USD
3.430
+0.010 (0.29%)
At close: Jul 19, 2024, 4:00 PM
3.480
+0.050 (1.46%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Mural Oncology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
 TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021
Selling, General & Admin
-30.7117.7315.55
Research & Development
-165.53167.19159.82
Operating Expenses
-196.24184.92175.37
Operating Income
--196.24-184.92-175.37
Other Expense / Income
--0.95--
Pretax Income
--195.29-184.92-175.37
Income Tax
-12.164.880.07
Net Income
--207.45-189.81-175.43
Shares Outstanding (Basic)
171717-
Shares Outstanding (Diluted)
-1717-
Shares Change
0.62%---
EPS (Basic)
--12.43-11.37-
EPS (Diluted)
--12.43-11.37-
Free Cash Flow
--197.7-174.1-161.05
Free Cash Flow Per Share
--11.85-10.43-
EBITDA
--192.72-183.38-173.89
Depreciation & Amortization
-2.571.541.47
EBIT
--195.29-184.92-175.37
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).